Dec, 25, 2021 – Israeli pharmaceutical giant Teva has announced the launch of the first available generic version of a nasal spray used to treat opioid overdose.
Naloxone hydrochloride nasal spray, currently sold under the brand name Narcan, is used in emergencies to block the effects of opioid drugs.
The US has in recent years faced a crisis over opioid drug addiction, which has caused more than 500,000 overdose deaths in the country over the past 20 years.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…